Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA ‑374a/forkhead box O1 signaling axis.
In conclusion, propofol downregulated miR‑374a and modulated the FOXO1 pathway to reduce proliferation and DDP resistance in ovarian cancer cells.
PMID: 32016462 [PubMed - as supplied by publisher]
Source: Molecular Medicine Reports - Category: Molecular Biology Tags: Mol Med Rep Source Type: research
More News: Cancer | Cancer & Oncology | Diprivan | Genetics | Molecular Biology | Multidrug Resistance | Ovarian Cancer | Ovaries | Propofol | Study | Women